Dr. Minor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2200 Webster St
#511
San Francisco, CA 94115
Education & Training
- Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 1976 - 1978
- California Pacific Medical CenterResidency, Internal Medicine, 1974 - 1976
- University of California San Francisco School of MedicineClass of 1974
Certifications & Licensure
- CA State Medical License 1975 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Clinical Trial of Sutent to Treat Metastatic Melanoma Start of enrollment: 2007 Sep 01
- Biochemotherapy and Bevacizumab Followed by Consolidation Therapy With Ipilimumab for Metastatic Melanoma Start of enrollment: 2010 Dec 01
- Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma Start of enrollment: 2013 Jul 12
- Join now to see all
Publications & Presentations
PubMed
- 102 citationsPhase 2 Study of Intralesional PV-10 in Refractory Metastatic MelanomaJohn F. Thompson, Sanjiv S. Agarwala, B. Mark Smithers, Merrick I. Ross, Charles R. Scoggins
Annals of Surgical Oncology. 2015-07-01 - 104 citationsReleasing the Brake on the Immune System: Ipilimumab in Melanoma and Other TumorsAhmad A. Tarhini, Ernest Lo, David R. Minor
Cancer Biotherapy & Radiopharmaceuticals. 2010-12-01 - 682 citationsCombined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled...F. Stephen Hodi, Jason Chesney, Anna C. Pavlick, Caroline Robert, Kenneth F. Grossmann
The Lancet. Oncology. 2016-11-01
Press Mentions
- Promising New Drug Could Help Patients Battling Deadly and Difficult to Treat Form of MelanomaMarch 8th, 2012
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: